All In Biotech

Drug Trial Radar · NCT07737743

A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

A Randomized, Double-blind, Placebo-controlled, Multicenter Phase 2a/b Study Assessing the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 344 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

344

Planned (sponsor's estimate)

Start

Aug 24, 2026

Primary completion

Feb 19, 2029

Study completion Mar 19, 2029

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Jul 30, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Sequential
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate efficacy, safety, and tolerability of DDY391 up to 52 weeks in participants with Sjögren's disease (SjD) and to determine the dose response relationship of DDY391 in participants with SjD, to support dose selection for Phase 3.

Conditions

  • Sjögren's Disease

Interventions

  • DDY391Drug

    DDY391 dose level 1 DDY391 dose level 2 DDY391 dose level 3

  • PlaceboDrug

    Matching Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part A and B: Change from baseline in ESSDAI scoreTime frame: Baseline, Week 24
  2. Part C: Change from baseline in ESSPRITime frame: Baseline, Week 24

Locations

31 sites in 9 countries. Site status is shown where the registry gives one.

  • Arizona Arthritis and Rheumatology Associates PLLC

    Avondale, Arizona · Recruiting

  • Clinical Res Of W Florida

    Clearwater, Florida · Recruiting

  • Clinical Research of West Florida Inc

    Tampa, Florida · Recruiting

  • Chicago Clinical Research Inst

    Chicago, Illinois · Recruiting

  • Willow Rheumatology Wellness

    Willowbrook, Illinois · Recruiting

  • RAO Research LLC

    Oklahoma City, Oklahoma · Recruiting

  • Altoona Center for Clin Res

    Duncansville, Pennsylvania · Recruiting

  • Rheumatology Specialty Center - Willow Grove Office

    Willow Grove, Pennsylvania · Recruiting

  • Shelby Research LLC

    Memphis, Tennessee · Recruiting

  • Stryde Research-Allen Arthritis

    Allen, Texas · Recruiting

  • Novel Research LLC

    Bellaire, Texas · Recruiting

  • Arthritis Care of Texas

    Corpus Christi, Texas · Recruiting

  • Novartis Investigative Site

    Southport, Queensland, Australia · Recruiting

  • Novartis Investigative Site

    Nedlands, Western Australia, Australia · Recruiting

  • Novartis Investigative Site

    Rimouski, Quebec, Canada · Recruiting

  • Novartis Investigative Site

    Sherbrooke, Quebec, Canada · Recruiting

  • Novartis Investigative Site

    Trois-Rivières, Quebec, Canada · Recruiting

  • Novartis Investigative Site

    Beijing, China · Recruiting

  • Novartis Investigative Site

    Beijing, China · Recruiting

  • Novartis Investigative Site

    Hefei, Anhui, China · Recruiting

  • Novartis Investigative Site

    Nanjing, Jiangsu, China · Recruiting

  • Novartis Investigative Site

    Taiyuan, Shanxi, China · Recruiting

  • Novartis Investigative Site

    Bogota, Cundinamarca, Colombia · Recruiting

  • Novartis Investigative Site

    Paris, France · Recruiting

  • Novartis Investigative Site

    Kaposvár, Hungary · Recruiting

  • Novartis Investigative Site

    Kfar Saba, Israel · Recruiting

  • Novartis Investigative Site

    Petah Tikva, Israel · Recruiting

  • Novartis Investigative Site

    Ramat Gan, Israel · Recruiting

  • Novartis Investigative Site

    Tel Aviv, Israel · Recruiting

  • Novartis Investigative Site

    Tsrifin, Israel · Recruiting

  • Novartis Investigative Site

    Groningen, Provincie Groningen, Netherlands · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.